El Tayebi HM - Search Results

1

MicroRNA‑155 modulation of CD8⁺ T‑cell activity personalizes response to disease‑modifying therapies of patients with relapsing‑remitting multiple sclerosis.

Elkhodiry AA, Zamzam DA, El Tayebi HM. Elkhodiry AA, et al. Among authors: el tayebi hm. Med Int (Lond). 2023 Mar 20;3(2):20. doi: 10.3892/mi.2023.80. eCollection 2023 Mar-Apr. Med Int (Lond). 2023. PMID: 37032715 Free PMC article.

2

Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.

El Khodiry A, Afify M, El Tayebi HM. El Khodiry A, et al. Among authors: el tayebi hm. World J Gastroenterol. 2018 Feb 7;24(5):549-572. doi: 10.3748/wjg.v24.i5.549. World J Gastroenterol. 2018. PMID: 29434445 Free PMC article. Review.

3

Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?

Elgohary S, Elkhodiry AA, Amin NS, Stein U, El Tayebi HM. Elgohary S, et al. Among authors: el tayebi hm. Cells. 2021 Feb 2;10(2):302. doi: 10.3390/cells10020302. Cells. 2021. PMID: 33540625 Free PMC article. Review.

4

From Whole Blood to Isolated Pro-Metastasis Immune Cells: An Ex Vivo Approach to Isolate and Manipulate Immune Cells Contributing to Tumor Metastasis.

Samir A, El Khodiry AA, ElTayebi HM. Samir A, et al. Methods Mol Biol. 2021;2294:209-218. doi: 10.1007/978-1-0716-1350-4_15. Methods Mol Biol. 2021. PMID: 33742404

5

miR-155 and functional proteins of CD8+ T cells as potential prognostic biomarkers for relapsing-remitting multiple sclerosis.

Elkhodiry AA, Zamzam DA, El Tayebi HM. Elkhodiry AA, et al. Among authors: el tayebi hm. Mult Scler Relat Disord. 2021 Aug;53:103078. doi: 10.1016/j.msard.2021.103078. Epub 2021 Jun 11. Mult Scler Relat Disord. 2021. PMID: 34171684

6

Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis.

Elkhodiry AA, El Tayebi HM. Elkhodiry AA, et al. Among authors: el tayebi hm. Noncoding RNA Res. 2021 Dec 7;6(4):187-199. doi: 10.1016/j.ncrna.2021.12.002. eCollection 2021 Dec. Noncoding RNA Res. 2021. PMID: 34938929 Free PMC article.

7

A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.

Assal RA, El Tayebi HM, Hosny KA, Esmat G, Abdelaziz AI. Assal RA, et al. Among authors: el tayebi hm. Mol Med Rep. 2015 Jul;12(1):645-50. doi: 10.3892/mmr.2015.3382. Epub 2015 Feb 24. Mol Med Rep. 2015. PMID: 25739014

8

More gain, less pain: How resistance training affects immune system functioning in multiple sclerosis patients: A review.

Amin NS, El Tayebi HM. Amin NS, et al. Among authors: el tayebi hm. Mult Scler Relat Disord. 2023 Jan;69:104401. doi: 10.1016/j.msard.2022.104401. Epub 2022 Nov 12. Mult Scler Relat Disord. 2023. PMID: 36403379 Review.

9

Rs205764 and rs547311 in linc00513 may influence treatment responses in multiple sclerosis patients: A pharmacogenomics Egyptian study.

Amin NS, Abd El-Aziz MK, Hamed M, Moustafa RR, El Tayebi HM. Amin NS, et al. Among authors: el tayebi hm. Front Immunol. 2023 Feb 17;14:1087595. doi: 10.3389/fimmu.2023.1087595. eCollection 2023. Front Immunol. 2023. PMID: 36883100 Free PMC article.

10

What's your cup of tea? The role of herbal compounds in the management of multiple sclerosis.

Abdelgaied MY, Abd El-Aziz MK, Amin NS, El Tayebi HM. Abdelgaied MY, et al. Among authors: el tayebi hm. Mult Scler Relat Disord. 2023 Aug;76:104799. doi: 10.1016/j.msard.2023.104799. Epub 2023 Jun 7. Mult Scler Relat Disord. 2023. PMID: 37300922 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page